SHORT-TERM AND LONG-TERM EFFICACY OF BREXPIPRAZOLE IN ADULTS WITH SCHIZOPHRENIA: EFFECT ACROSS MARDER FACTORS

被引：0
作者：
Weiss, Catherine [1 ]
Forbes, Andy [1 ]
Hobart, Mary [1 ]
Pfister, Stephanie [1 ]
Ouyang, John [1 ]
Weiller, Emmanuelle [2 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[2] H Lundbeck & Co AS, Copenhagen, Denmark
来源：
SCHIZOPHRENIA BULLETIN | 2017年 / 43卷
关键词：
DOUBLE-BLIND; TRIAL;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
SA115
引用
收藏
页码：S154 / S154
页数：1
相关论文
共 3 条
  • [1] Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
    Correll, Christoph U.
    Skuban, Aleksandar
    Ouyang, John
    Hobart, Mary
    Pfister, Stephanie
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    Sanchez, Raymond
    Eriksson, Hans
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (09) : 870 - 880
  • [2] Fleischhacker WW, 2016, INT J NEUROPSYCHOPHA
  • [3] A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia
    Kane, John M.
    Skuban, Aleksandar
    Ouyang, John
    Hobart, Mary
    Pfister, Stephanie
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    Sanchez, Raymond
    Eriksson, Hans
    [J]. SCHIZOPHRENIA RESEARCH, 2015, 164 (1-3) : 127 - 135
1